Last Updated : January 9, 2020
See Pharmaceutical Reviews Update – Issue 12 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include:
- A new process for the submission and review of cell and gene therapies
- Updated guidelines on fees for CADTH pharmaceutical reviews
- Pending updates to the category 1 requirements
- Pending changes to CADTH conflict of interest policies
- A reminder about CADTH’s redaction policy
- Information about a new advisory committee for CADTH’s drug portfolio
Last Updated : January 9, 2020